Amphastar Pharmaceuticals Inc logo

AMPH - Amphastar Pharmaceuticals Inc News Story

$18.68 0.6  3.5%

Last Trade - 07/05/21

Sector
Healthcare
Size
Mid Cap
Market Cap £638.0m
Enterprise Value £628.8m
Revenue £250.4m
Position in Universe 2962nd / 6858

BRIEF-Amphastar Pharmaceuticals Receives FDA Approval For Dextrose Injection

Mon 29th March, 2021 12:24pm
March 29 (Reuters) - Amphastar Pharmaceuticals Inc  AMPH.O :
    * AMPHASTAR PHARMACEUTICALS RECEIVES FDA APPROVAL FOR
DEXTROSE
INJECTION

Source text for Eikon:  ID:nGNXCHFvl 
Further company coverage:  AMPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.